PSMB6
PSMB6 (Proteasome subunit beta type-6) is an enzyme. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it. Tied to Multiple myeloma, Non-Hodgkin lymphoma and Mantle cell lymphoma.
Overview
Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins.
Open Targets scores its association with cancer at 0.62 (direct and indirect evidence; datatypes literature 0.66, genetic association 0.00, clinical 0.99).
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · PSMB6 (Proteasome subunit beta type-6) is an enzyme. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it. Tied to Multiple myeloma, Non-Hodgkin lymphoma and Mantle cell lymphoma.
- 1 · What it is
PSMB6 (Proteasome subunit beta type-6) is an enzyme. The public catalogues list it as a drug target, and an approved or late-stage drug is recorded against it. Tied to Multiple myeloma, Non-Hodgkin lymphoma and Mantle cell lymphoma.
- 2 · What goes wrong in cancer
Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles.
- 3 · How drugs use it
No product in this corpus aims at PSMB6 yet. Inhibitors are shaped to fit the enzyme's active site so the reaction the cancer relies on stops.
External identifiers
Sources: HGNC HGNC:9543 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt P28072 (protein name, function text, keywords and locations (REST API)); Open Targets ENSG00000142507 (association with cancer (MONDO_0004992) 0.62; per-cancer scores at or above 0.5: plasma cell myeloma 0.61, non-Hodgkin lymphoma 0.57, mantle cell lymphoma 0.54 (GraphQL API, CC0))
Biology
Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). Location: Cytoplasm; Nucleus (UniProt). Locus 17p13.2 (HGNC).
- Multiple myeloma: Open Targets association 0.61 with plasma cell myeloma (MONDO_0009693)
- Non-Hodgkin lymphoma: Open Targets association 0.57 with non-Hodgkin lymphoma (MONDO_0018908)
- Mantle cell lymphoma: Open Targets association 0.54 with mantle cell lymphoma (MONDO_0018876)
Notes
top- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: Open Targets known-drug datatype score 0.99. Evidence tier "approved-drug" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
Latest papers
topQuery for this target: (TITLE:"PSMB6" OR ABSTRACT:"PSMB6" OR TITLE:"proteasome 20S subunit beta 6" OR ABSTRACT:"proteasome 20S subunit beta 6" OR TITLE:"Proteasome subunit beta type-6" OR ABSTRACT:"Proteasome subunit beta type-6" OR TITLE:"DELTA" OR ABSTRACT:"DELTA") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PSMB6, not a curated reading list.
Similar pages
not linked directly; found by shared links- TargetADRM1
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA1
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA2
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA3
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA4
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA5
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA6
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.
- TargetPSMA7
Shares Mantle cell lymphoma, Non-Hodgkin lymphoma (all types), Multiple myeloma, Open Targets Platform.